Molecular structure of aggregated amyloid-β: Insights from solid-state nuclear magnetic resonance

Cold Spring Harbor Perspectives in Medicine

Volumn 6, Issue 8, 2016, Pages

  Tycko, Robert ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40];

ARTICLE; BRAIN TISSUE; CHEMICAL STRUCTURE; HUMAN; IN VITRO STUDY; NUCLEAR MAGNETIC RESONANCE; PROTEIN AGGREGATION; STEADY STATE NUCLEAR MAGNETIC RESONANCE; STRUCTURAL MODEL; BRAIN; CHEMISTRY; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROCEDURES; ULTRASTRUCTURE;

AMYLOID BETA-PEPTIDES; BRAIN; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE;

EID: 84982824814     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a024083     Document Type: Article

References (111)

1. Ahmed M, Davis J, Aucoin D, Sato T, Ahuja S, Aimoto S, Elliott JI, Van Nostrand WE, Smith SO. 2010. Structural conversion of neurotoxic amyloid-b1–42 oligomers to fibrils. Nat Struct Mol Biol 17: 561–567.
2. Antzutkin ON, Balbach JJ, Leapman RD, Rizzo NW, Reed J, Tycko R. 2000. Multiple quantum solid state NMR indicates a parallel, not antiparallel, organization of b-sheets in Alzheimer’s b-amyloid fibrils. Proc Natl Acad Sci 97: 13045–13050.
3. Antzutkin ON, Leapman RD, Balbach JJ, Tycko R. 2002. Supramolecular structural constraints on Alzheimer’s b-amyloid fibrils from electron microscopy and solid state nuclear magnetic resonance. Biochemistry 41: 15436–15450.
4. Antzutkin ON, Balbach JJ, Tycko R. 2003. Site-specific identification of non-b-strand conformations in Alzheimer’s b-amyloid fibrils by solid state NMR. Biophys J 84: 3326–3335.
5. Arai H, Lee VM, Messinger ML, Greenberg BD, Lowery DE, Trojanowski JQ. 1991. Expression patterns of b-amyloid precursor protein (b-APP) in neural and nonneural human tissues from Alzheimer’s-disease and control subjects. Ann Neurol 30: 686–693.
6. Astbury WT, Beighton E, Parker KD. 1959. The cross-b configuration in supercontracted proteins. Biochim Biophys Acta 35: 17–25.
7. Balbach JJ, Ishii Y, Antzutkin ON, Leapman RD, Rizzo NW, Dyda F, Reed J, Tycko R. 2000. Amyloid fibril formation by Ab16 –22, a seven-residue fragment of the Alzheimer’s b-amyloid peptide, and structural characterization by solid state NMR. Biochemistry 39: 13748–13759.
8. Balbach JJ, Petkova AT, Oyler NA, Antzutkin ON, Gordon DJ, Meredith SC, Tycko R. 2002. Supramolecular structure in full-length Alzheimer’s b-amyloid fibrils: Evidence for a parallel b-sheet organization from solid state nuclear magnetic resonance. Biophys J 83: 1205–1216.
9. Bayro MJ, Debelouchina GT, Eddy MT, Birkett NR, MacPhee CE, Rosay M, Maas WE, Dobson CM, Griffin RG. 2011. Intermolecular structure determination of amyloid fibrils with magic-angle spinning and dynamic nuclear polarization NMR. J Am Chem Soc 133: 13967–13974.
10. Bedrood S, Li YY, Isas JM, Hegde BG, Baxa U, Haworth IS, Langen R. 2012. Fibril structure of human islet amyloid polypeptide. J Biol Chem 287: 5235–5241.
11. Benzinger TL, Gregory DM, Burkoth TS, Miller-Auer H, Lynn DG, Botto RE, Meredith SC. 1998. Propagating structure of Alzheimer’s b-amyloid(10 –35) is parallel bsheet with residues in exact register. Proc Natl Acad Sci 95: 13407–13412.
12. Bergh J, Zetterström P, Andersen PM, Brännström T, Graffmo KS, Jonsson PA, Lang LS, Danielsson J, Oliveberg M, Marklund SL. 2015. Structural and kinetic analysis of protein-aggregate strains in vivo using binary epitope mapping. Proc Natl Acad Sci 112: 4489–4494.
13. Bertini I, Gonnelli L, Luchinat C, Mao JF, Nesi A. 2011. A new structural model of Ab40 fibrils. J Am Chem Soc 133: 16013–16022.
14. Brännström K, Öhman A, Lindhagen-Persson M, Olofsson A. 2013. Ca2þ enhances Ab polymerization rate and fibrillar stability in a dynamic manner. Biochem J 450: 189–197.
15. Bu ZM, Shi Y, Callaway DJE, Tycko R. 2007. Molecular alignment within b-sheets in Ab14 –23 fibrils: Solid state NMR experiments and theoretical predictions. Biophys J 92: 594–602.
16. Buchete NV, Tycko R, Hummer G. 2005.Molecular dynamics simulations of Alzheimer’s b-amyloid protofilaments. J Mol Biol 353: 804–821.
17. Chaney MO, Webster SD, Kuo YM, Roher AE. 1998.Molecular modeling of the amyloid b 1–42 peptide from Alzheimer’s disease. Protein Eng 11: 761–767.
18. Chen B, Thurber KR, Shewmaker F, Wickner RB, Tycko R. 2009.Measurement of amyloid fibril mass-per-length by tilted-beam transmission electron microscopy. Proc Natl Acad Sci 106: 14339–14344.
19. Chimon S, Ishii Y. 2005. Capturing intermediate structures of Alzheimer’s b-amyloid, Ab(1–40), by solid stateNMR spectroscopy. J Am Chem Soc 127: 13472–13473.
20. Chimon S, Shaibat MA, Jones CR, Calero DC, Aizezi B, Ishii Y. 2007. Evidence of fibril-like b-sheet structures in a neurotoxic amyloid intermediate of Alzheimer’s b-amyloid. Nat Struct Mol Biol 14: 1157–1164.
21. Cobb NJ, Sonnichsen FD, McHaourab H, Surewicz WK. 2007. Molecular architecture of human prion protein amyloid: A parallel, in-register b-structure. Proc Natl Acad Sci 104: 18946–18951.
22. Cohen M, Kim C, Haldiman T, Elhag M, Tatsuoka C, Zhang SL, Haines J, Lerner A, Safar J. 2015. Distinct strains of amyloid b prions implicated in rapidly progressive Alzheimer disease. Prion 9: S76–S77.
23. Cukalevski R, Yang XT, Meisl G, Weininger U, Bernfur K, Frohm B, Knowles TPJ, Linse S. 2015. The Ab40 and Ab42 peptides self-assemble into separate homomolecular fibrils in binary mixtures but cross-react during primary nucleation. Chem Sci 6: 4215–4233.
24. Deshpande A, Mina E, Glabe C, Busciglio J. 2006. Different conformations of amyloid b induce neurotoxicity by distinct mechanisms in human cortical neurons. J Neurosci 26: 6011–6018.
25. Eanes ED, Glenner GG. 1968. X-ray diffraction studies on amyloid filaments. J Histochem Cytochem 16: 673–677.
26. George AR, Howlett DR. 1999. Computationally derived structural models of the b-amyloid found in Alzheimer’s disease plaques and the interaction with possible aggregation inhibitors. Biopolymers 50: 733–741.
27. Glabe CG. 2008. Structural classification of toxic amyloid oligomers. J Biol Chem 283: 29639–29643.
28. Goldsbury CS, Wirtz S, Müller SA, Sunderji S, Wicki P, Aebi U, Frey P. 2000. Studies on the in vitro assembly of Ab 1–40: Implications for the search for Ab fibril formation inhibitors. J Struct Biol 130: 217–231.
29. Goldsbury C, Frey P, Olivieri V, Aebi U, Müller SA. 2005. Multiple assembly pathways underlie amyloid-b fibril polymorphisms. J Mol Biol 352: 282–298.
30. Grabowski TJ, Cho HS, Vonsattel JPG, Rebeck GW, Greenberg SM. 2001. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 49: 697–705.
31. Gravina SA, Ho LB, Eckman CB, Long KE, Otvos L, Younkin LH, Suzuki N, Younkin SG. 1995. Amyloid-b protein (Ab) in Alzheimer’s-disease brain: Biochemical and immunocytochemical analysis with antibodies specific for forms ending at Ab-40 or Ab-42(43). J Biol Chem 270: 7013–7016.
32. Gregory DM, Mitchell DJ, Stringer JA, Kiihne S, Shiels JC, Callahan J, Mehta MA, Drobny GP. 1995. Windowless dipolar recoupling: The detection of weak dipolar couplings between spin 1/2 nuclei with large chemical shift anisotropies. Chem Phys Lett 246: 654–663.
33. Griffiths JM, Ashburn TT, Auger M, Costa PR, Griffin RG, Lansbury PT. 1995. Rotational resonance solid stateNMR elucidates a structural model of pancreatic amyloid. J Am Chem Soc 117: 3539–3546.
34. Gullion T, Schaefer J. 1989. Rotational-echo double-resonance NMR. J Magn Reson 81: 196–200.
35. Haass C, Selkoe DJ. 1993. Cellular processing of b-amyloid precursor protein and the genesis of amyloid b-peptide. Cell 75: 1039–1042.
36. Hardy J. 2006. Has the amyloid cascade hypothesis for Alzheimer’s disease been proved? Curr Alzheimer Res 3: 71–73.
37. Heilbronner G, Eisele YS, Langer F, Kaeser SA, Novotny R, Nagarathinam A, Aslund A, Hammarström P, Nilsson KPR, Jucker M. 2013. Seeded strain-like transmission of b-amyloid morphotypes in APP transgenic mice. EMBO Rep 14: 1017–1022.
38. Hilbich C, Kisters-Woike B, Reed J, Masters CL, Beyreuther K. 1991. Aggregation and secondary structure of synthetic amyloid bA4 peptides of Alzheimer’s disease. J Mol Biol 218: 149–163.
39. Hu KN, Qiang W, Bermejo GA, Schwieters CD, Tycko R. 2012. Restraints on backbone conformations in solid state NMR studies of uniformly labeled proteins from quantitative amide 15N–15N and carbonyl 13C–13C dipolar recoupling data. J Magn Reson 218: 115–127.
40. Huang DT, Zimmerman MI, Martin PK, Nix AJ, Rosenberry TL, Paravastu AK. 2015. Antiparallel b-sheet structure within the C-terminal region of 42-residue Alzheimer’s amyloid-b peptides when they form 150-kDa oligomers. J Mol Biol 427: 2319–2328.
41. Jaroniec CP, Tounge BA, Herzfeld J, Griffin RG. 2001. Frequency selective heteronuclear dipolar recoupling in rotating solids: Accurate 13C–15N distance measurements in uniformly 13C, 15N-labeled peptides. J Am Chem Soc 123: 3507–3519.
42. Jaroniec CP, Filip C, Griffin RG 2002. 3D TEDOR NMR experiments for the simultaneous measurement of multiple carbon–nitrogen distances in uniformly 13C, 15Nlabeled solids. J Am Chem Soc 124: 10728–10742.
43. Jaroniec CP, MacPhee CE, Bajaj VS, McMahon MT, Dobson CM, Griffin RG. 2004. High-resolution molecular structure of a peptide in an amyloid fibril determined by magic angle spinning NMR spectroscopy. Proc Natl Acad Sci 101: 711–716.
44. Jiménez JL, Guijarro JL, Orlova E, Zurdo J, Dobson CM, Sunde M, Saibil HR. 1999. Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing. Embo J 18: 815–821.
45. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG. 2003. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300: 486–489.
46. Kheterpal I, Wetzel R. 2006.Hydrogen/deuteriumexchange mass spectrometry—A window into amyloid structure. Acc Chem Res 39: 584–593.
47. Kheterpal I, Zhou S, Cook KD, Wetzel R. 2000. Ab amyloid fibrils possess a core structure highly resistant to hydrogen exchange. Proc Natl Acad Sci 97: 13597–13601.
48. Kheterpal I, Williams A, Murphy C, Bledsoe B, Wetzel R. 2001. Structural features of the Ab amyloid fibril elucidated by limited proteolysis. Biochemistry 40: 11757–11767.
49. Klinger AL, Kiselar J, Ilchenko S, Komatsu H, Chance MR, Axelsen PH. 2014. A synchrotron-based hydroxyl radical footprinting analysis of amyloid fibrils and prefibrillar intermediates with residue-specific resolution. Biochemistry 53: 7724–7734.
50. Klunk WE, Engler H, Nordberg A, Wang YM, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang GF, Estrada S, et al. 2004. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh compound-B. Ann Neurol 55: 306–319.
51. Kodali R, Williams AD, Chemuru S, Wetzel R. 2010. Ab(1–40) forms five distinct amyloid structures whose b-sheet contents and fibril stabilities are correlated. J Mol Biol 401: 503–517.
52. Kuo YM, Emmerling MR, Vigo-Pelfrey C, Kasunic TC, Kirkpatrick JB, Murdoch GH, Ball MJ, Roher AE. 1996. Water-soluble Ab(N-40, N-42) oligomers in normal and Alzheimer disease brains. J Biol Chem 271: 4077–4081.
53. Ladiwala ARA, Litt J, Kane RS, Aucoin DS, Smith SO, Ranjan S, Davis J, Van Nostrand WE, Tessier PM. 2012. Conformational differences between two amyloid b oligomers of similar size and dissimilar toxicity. J Biol Chem 287: 24765–24773.
54. Laganowsky A, Liu C, Sawaya MR, Whitelegge JP, Park J, Zhao ML, Pensalfini A, Soriaga AB, Landau M, Teng PK, et al. 2012. Atomic view of a toxic amyloid small oligomer. Science 335: 1228–1231.
55. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, et al. 1998. Diffusible, nonfibrillar ligands derived from Ab1–42 are potent central nervous system neurotoxins. Proc Natl Acad Sci 95: 6448–6453.
56. Lansbury PT, Costa PR, Griffiths JM, Simon EJ, Auger M, Halverson KJ, Kocisko DA, Hendsch ZS, Ashburn TT, Spencer RGS, et al. 1995. Structural model for the bamyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide. Nat Struct Biol 2: 990–998.
57. Lasagna-Reeves CA, Glabe CG, Kayed R. 2011. Amyloid-b annular protofibrils evade fibrillar fate in Alzheimer disease brain. J Biol Chem 286: 22122–22130.
58. Lazo ND, Downing DT. 1998. Amyloid fibrils may be assembled from b-helical protofibrils. Biochemistry 37: 1731–1735.
59. Lee JP, Stimson ER, Ghilardi JR, Mantyh PW, Lu YA, Felix AM, Llanos W, Behbin A, Cummings M, Van Criekinge M, et al. 1995. 1HNMR of Ab amyloid peptide congeners inwater solution. Conformational changes correlatewith plaque competence. Biochemistry 34: 5191–5200.
60. Lendel C, Bjerring M, Dubnovitsky A, Kelly RT, Filippov A, Antzutkin ON, Nielsen NC, Härd T. 2014. A hexameric peptide barrel as building block of amyloid-b protofibrils. Angew Chem Int Ed Engl 53: 12756–12760.
61. Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH. 2006. A specific amyloid-b protein assembly in the brain impairs memory. Nature 440: 352–357.
62. Lesne SE, Sherman MA, Grant M, Kuskowski M, Schneider JA, Bennett DA, Ashe KH. 2013. Brain amyloid-b oligomers in ageing and Alzheimer’s disease. Brain 136: 1383–1398.
63. Li LP, Darden TA, Bartolotti L, Kominos D, Pedersen LG. 1999. An atomic model for the pleated b-sheet structure of Ab amyloid protofilaments. Biophys J 76: 2871–2878.
64. Liu P, Reed MN, Kotilinek LA, Grant MKO, Forster CL, Qiang W, Shapiro SL, Reichl JH, Chiang ACA, Jankowsky JL, et al. 2015. Quaternary structure defines a large class of amyloid-b oligomers neutralized by sequestration. Cell Rep 11: 1760–1771.
65. Lopez del Amo JM, Fink U, Dasari M, Grelle G, Wanker EE, Bieschke J, Reif B. 2012. Structural properties of EGCGinduced, nontoxic Alzheimer’s disease Ab oligomers. J Mol Biol 421: 517–524.
66. Lu JX, Qiang W, Yau WM, Schwieters CD, Meredith SC, Tycko R. 2013. Molecular structure of b-amyloid fibrils in Alzheimer’s disease brain tissue. Cell 154: 1257–1268.
67. Lührs T, Ritter C, Adrian M, Riek-Loher D, Bohrmann B, Döbeli H, Schubert D, Riek R. 2005. 3D structure of Alzheimer’s amyloid-b(1–42) fibrils. Proc Natl Acad Sci 102: 17342–17347.
68. Margittai M, Langen R. 2008. Fibrils with parallel in-register structure constitute a major class of amyloid fibrils: Molecular insights from electron paramagnetic resonance spectroscopy. Q Rev Biophys 41: 265–297.
69. McDonald M, Box H, Bian W, Kendall A, Tycko R, Stubbs G. 2012. Fiber diffraction data indicate a hollow core for the Alzheimer’s Ab 3-fold symmetric fibril. J Mol Biol 423: 454–461.
70. Meinhardt J, Sachse C, Hortschansky P, Grigorieff N, Fändrich M. 2009. Ab(1–40) fibril polymorphism implies diverse interaction patterns in amyloid fibrils. J Mol Biol 386: 869–877.
71. Nelson R, Sawaya MR, Balbirnie M, Madsen AØ, Riekel C, Grothe R, Eisenberg D. 2005. Structure of the cross-b spine of amyloid-like fibrils. Nature 435: 773–778.
72. Olofsson A, Lindhagen-Persson M, Sauer-Eriksson AE, Öhman A. 2007. Amide solvent protection analysis demonstrates that amyloid-b(1–40) and amyloid-b(1–42) form different fibrillar structures under identical conditions. Biochem J 404: 63–70.
73. Paravastu AK, Leapman RD, Yau WM, Tycko R. 2008. Molecular structural basis for polymorphism in Alzheimer’s b-amyloid fibrils. Proc Natl Acad Sci 105: 18349–18354.
74. Paravastu AK, Qahwash I, Leapman RD, Meredith SC, Tycko R. 2009. Seeded growth of b-amyloid fibrils from Alzheimer’s brain-derived fibrils produces a distinct fibril structure. Proc Natl Acad Sci 106: 7443–7448.
75. Parthasarathy S, Inoue M, Xiao YL, Matsumura Y, Nabeshima Y, Hoshi M, Ishii Y. 2015. Structural insight into an Alzheimer’s brain-derived spherical assembly of amyloid b by solid-state NMR. J Am Chem Soc 137: 6480–6483.
76. Pensalfini A, Albay R, Rasool S, Wu JW, Hatami A, Arai H, Margol L, Milton S, Poon WW, Corrada MM, et al. 2014. Intracellular amyloid and the neuronal origin of Alzheimer neuritic plaques. Neurobiol Dis 71: 53–61.
77. Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD, Delaglio F, Tycko R. 2002. A structural model for Alzheimer’s b-amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci 99: 16742–16747.
78. Petkova AT, Buntkowsky G, Dyda F, Leapman RD, Yau WM, Tycko R. 2004. Solid state NMR reveals a pH-dependent antiparallel b-sheet registry in fibrils formed by a b-amyloid peptide. J Mol Biol 335: 247–260.
79. Petkova AT, Leapman RD, Guo ZH, Yau WM, Mattson MP, Tycko R. 2005. Self-propagating, molecular-level polymorphism in Alzheimer’s b-amyloid fibrils. Science 307: 262–265.
80. Petkova AT, Yau WM, Tycko R. 2006. Experimental constraints on quaternary structure in Alzheimer’s b-amyloid fibrils. Biochemistry 45: 498–512.
81. Potapov A, Yau WM, Ghirlando R, Thurber KR, Tycko R. 2015. Successive stages of amyloid-b self-assembly characterized by solid state nuclear magnetic resonance with dynamic nuclear polarization. JAmChem Soc 137: 8294–8307.
82. Qiang W, Yau WM, Tycko R. 2011. Structural evolution of Iowa mutant b-amyloid fibrils from polymorphic to homogeneous states under repeated seeded growth. J Am Chem Soc 133: 4018–4029.
83. Qiang W, Yau WM, Luo YQ, Mattson MP, Tycko R. 2012. Antiparallel b-sheet architecture in Iowa-mutant bamyloid fibrils. Proc Natl Acad Sci 109: 4443–4448.
84. Qiang W, Kelley K, Tycko R. 2013. Polymorph-specific kinetics and thermodynamics of b-amyloid fibril growth. J Am Chem Soc 135: 6860–6871.
85. Raleigh DP, Levitt MH, Griffin RG. 1988. Rotational resonance in solid state NMR. Chem Phys Lett 146: 71–76.
86. Sandberg A, Luheshi LM, Sollvander S, de Barros TP, Macao B, Knowles TPJ, Biverstal H, Lendel C, Ekholm-Petterson F, Dubnovitsky A, et al. 2010. Stabilization of neurotoxic Alzheimer amyloid-b oligomers by protein engineering. Proc Natl Acad Sci 107: 15595–15600.
87. Sarkar B, Mithu VS, Chandra B, Mandal A, Chandrakesan M, Bhowmik D, Madhu PK, Maiti S. 2014. Significant structural differences between transient amyloid-b oligomers and less-toxic fibrils in regions known to harbor familial Alzheimer’s mutations. Angew Chem Int Ed Engl 53: 6888–6892.
88. Sawaya MR, Sambashivan S, Nelson R, Ivanova MI, Sievers SA, Apostol MI, Thompson MJ, Balbirnie M, Wiltzius JJW, McFarlane HT, et al. 2007. Atomic structures of amyloid cross-b spines reveal varied steric zippers. Nature 447: 453–457.
89. Scheidt HA, Morgado I, Rothemund S, Huster D, Fändrich M. 2011. Solid stateNMRspectroscopic investigation of a b protofibrils: Implication of Ab-sheet remodeling upon maturation into terminal amyloid fibrils. Angew Chem Int Ed Engl 50: 2837–2840.
90. Scheidt HA, Morgado I, Huster D. 2012. Solid state NMR reveals a close structural relationship between amyloid-b protofibrils and oligomers. J Biol Chem 287: 22822–22826.
91. Schütz AK, Vagt T, Huber M, Ovchinnikova OY, Cadalbert R, Wall J, Güntert P, Böckmann A, Glockshuber R, Meier BH. 2014. Atomic-resolution three-dimensional structure of amyloid b fibrils bearing the Osaka mutation. Angew Chem Int Ed Engl 53: 1–6.
92. Sgourakis NG, Yau WM, Qiang W. 2015. Modeling an inregister, parallel “Iowa” Ab fibril structure using solid stateNMRdata from labeled samples with Rosetta. Structure 23: 216–227.
93. Stöhr J, Condello C, Watts JC, Bloch L, Oehler A, Nick M, DeArmond SJ, Giles K, DeGrado WF, Prusiner SB. 2014. Distinct synthetic Ab prion strains producing different amyloid deposits in bigenic mice. Proc Natl Acad Sci 111: 10329–10334.
94. Tay WM, Huang DT, Rosenberry TL, Paravastu AK. 2013. The Alzheimer’s amyloid-b(1–42) peptide forms offpathway oligomers and fibrils that are distinguished structurally by intermolecular organization. J Mol Biol 425: 2494–2508.
95. Tjernberg LO, Callaway DJ, Tjernberg A, Hahne S, Lilliehöök C, Terenius L, Thyberg J, Nordstedt C. 1999. A molecular model of Alzheimer amyloid b-peptide fibril formation. J Biol Chem 274: 12619–12625.
96. Tomic JL, Pensalfini A, Head E, Glabe CG. 2009. Soluble fibrillar oligomer levels are elevated in Alzheimer’s disease brain and correlate with cognitive dysfunction. Neurobiol Dis 35: 352–358.
97. Tomiyama T, Nagata T, Shimada H, Teraoka R, Fukushima A, Kanemitsu H, Takuma H, Kuwano R, Imagawa M, Ataka S, et al. 2008. A new amyloid-b variant favoring oligomerization in Alzheimer’s-type dementia. Ann Neurol 63: 377–387.
98. Török M, Milton S, Kayed R, Wu P, McIntire T, Glabe CG, Langen R. 2002. Structural and dynamic features of Alzheimer’s Ab peptide in amyloid fibrils studied by sitedirected spin labeling. J Biol Chem 277: 40810–40815.
99. Tycko R. 2007. Symmetry-based constant-time homonuclear dipolar recoupling in solid state NMR. J Chem Phys 126: 064506.
100. Tycko R. 2014. Physical and structural basis for polymorphism in amyloid fibrils. Prot Sci 23: 1528–1539.
101. Tycko R, Dabbagh G. 1990. Measurement of nuclear magnetic dipole–dipole couplings in magic angle spinning NMR. Chem Phys Lett 173: 461–465.
102. Tycko R, Wickner RB. 2013.Molecular structures of amyloid and prion fibrils: Consensus versus controversy. Acc Chem Res 46: 1487–1496.
103. Tycko R, Sciarretta KL, Orgel J, Meredith SC. 2009. Evidence for novel b-sheet structures in Iowa mutant b-amyloid fibrils. Biochemistry 48: 6072–6084.
104. Van Melckebeke H, Wasmer C, Lange A, Ab E, Loquet A, Böckmann A, Meier BH. 2010. Atomic-resolution threedimensional structure of HET-s(218–289) amyloid fibrils by solid state NMR spectroscopy. J Am Chem Soc 132: 13765–13775.
105. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ. 2002. Naturally secreted oligomers of amyloid b protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416: 535–539.
106. Watts JC, Condello C, Stöhr J, Oehler A, Lee J, DeArmond SJ, Lannfelt L, Ingelsson M, Giles K, Prusiner SB. 2014. Serial propagation of distinct strains of Ab prions from Alzheimer’s disease patients. Proc Natl Acad Sci 111: 10323–10328.
107. Williams AD, Sega M, Chen ML, Kheterpal I, Geva M, Berthelier V, Kaleta DT, Cook KD, Wetzel R. 2005. Structural properties of Ab protofibrils stabilized by a small molecule. Proc Natl Acad Sci 102: 7115–7120.
108. Wong DF, Rosenberg PB, Zhou Y, Kumar A, Raymont V, Ravert HT, Dannals RF, Nandi A, Brasic JR, Ye WG, et al. 2010. In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir F 18). J Nucl Med 51: 913–920.
109. Wu JW, Breydo L, Isas JM, Lee J, Kuznetsov YG, Langen R, Glabe C. 2010. Fibrillar oligomers nucleate the oligomerization of monomeric amyloid b but do not seed fibril formation. J Biol Chem 285: 6071–6079.
110. Xiao YL, Ma BY, McElheny D, Parthasarathy S, Long F, Hoshi M, Nussinov R, Ishii Y. 2015. Ab(1–42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer’s disease. Nat Struct Mol Biol 22: 499–505.
111. Yu LP, Edalji R, Harlan JE, Holzman TF, Lopez AP, Labkovsky B, Hillen H, Barghorn S, Ebert U, Richardson PL, et al. 2009. Structural characterization of a soluble amyloid b-peptide oligomer. Biochemistry 48: 1870–1877.